Invesco Ltd. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 145 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$3,703,254
-18.6%
416,096
-7.3%
0.00%0.0%
Q1 2024$4,547,965
+55.9%
448,960
+54.8%
0.00%0.0%
Q4 2023$2,917,571
-31.6%
290,017
-36.3%
0.00%0.0%
Q3 2023$4,268,512
-60.5%
455,551
+3.4%
0.00%
-66.7%
Q2 2023$10,810,788
-6.2%
440,717
-11.0%
0.00%0.0%
Q1 2023$11,525,818
-8.2%
495,308
-0.2%
0.00%
-25.0%
Q4 2022$12,559,479
+28.7%
496,226
-1.9%
0.00%
+33.3%
Q3 2022$9,755,000
-21.1%
505,946
+4.2%
0.00%
-25.0%
Q2 2022$12,370,000
+1096.3%
485,660
+1108.5%
0.00%
Q1 2022$1,034,000
-86.5%
40,188
-78.1%
0.00%
-100.0%
Q4 2021$7,671,000
+403.3%
183,201
+423.3%
0.00%
Q3 2021$1,524,000
+3.0%
35,008
+11.9%
0.00%
Q2 2021$1,479,000
+65.8%
31,290
+79.8%
0.00%
Q1 2021$892,000
+191.5%
17,398
+52.1%
0.00%
Q4 2020$306,000
-68.6%
11,438
-51.9%
0.00%
Q2 2020$975,00023,8040.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders